https://www.selleckchem.com/pr....oducts/dir-cy7-dic18
DOAC users had decreased risks of osteoporotic fractures (RR = 0.63; 95% CI 0.47-0.84) and hip/pelvic fractures (RR = 0.88; 95% CI 0.79-0.97) compared to those treated with VKAs. Conclusions Our meta-analysis suggested that the use of DOACs was associated with a reduced risk of any fracture compared with VKAs. Further studies should confirm our findings.To examine whether the expressions of 260 organelle crosstalk regulators (OCRGs) in 16 functional groups are modulated in 23 diseases and 28 tumors, we performed extensive -omics d
Beğen
Yorum Yap
Paylaş
